Navigation Links
Thyroid Releasing Hormone (TRH) Stimulation of Prolactin, 30 Minutes

ProductsThyroid Releasing Hormone (TRH) Stimulation of Prolactin, 30 Minutes
Company ARUP Laboratories
Item Thyroid Releasing Hormone (TRH) Stimulation of Prolactin, 30 Minutes
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Free T3 EIA Thyroid Function 025-BC-1006
2. Free T4 EIA Thyroid Function 025-BC-1008
3. TPO (Ab) RIA Thyroid Function 014-HD-90.1 Thyroid Peroxidase
4. TG (Ab) EIA Thyroid Function 012-MDKAT-1 Thyroglobulin anti-tg
5. Total T4 EIA Thyroid Function 025-BC-1007
6. TPO (Ab) EIA Thyroid Function 012-MDKAM-1 Thyroid Peroxidase
7. TG (Ab) RIA Thyroid Function 014-HD 27.1 Thyroglobulin
8. Total T3 EIA Thyroid Function 025-BC-1005
9. TSH EIA Thyroid Function 025-BC-1001
10. Ultrasensitive TSH EIA Thyroid Function 025-BC-1003
11. MSTS-1 Thyroid Shield
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
Medicine Products:
(Date:12/4/2008)...y staffing firm UNITEMP Temporary Personnel has ex...n to two full days for members of the Commerce and...ds Regional Chamber of Commerce, and the Mahwah Re... New Jersey (PRWEB) December 4, 2008 -- Lookin...Jersey staffing firm UNITEMP Temporary Personnel h...
(Date:12/4/2008)...s its operations in the Middle East , , LON...s Corporation (NYSE: PER ) ( www.perotsystems.co...Jordan has selected the company to manage the pilo...d healthcare information management system - at tw..., , Jordan is recognised as providing one of...
(Date:12/3/2008)...who are done having children feel responsible for ...eatment, yet more than half are against implanting...udy by researchers at Duke University Medical Cent...s on their heads," says Anne Drapkin Lyerly, MD, a...e, and lead investigator of the findings that appe...
(Date:12/3/2008)... GAC,s Work Advocating for Orphans and Highly Vuln... WASHINGTON, Dec. 4 Tod...100,000 end-of-year-grant from the Jolie-Pitt Foun...n Emergency Presidential Initiative for the World,..., ensure children are not left off the agenda duri...
Breaking Medicine News(10 mins):Health News:Unitemp Announces Unprecedented Temporary Staffing Services Guarantee 2Health News:Unitemp Announces Unprecedented Temporary Staffing Services Guarantee 3Health News:Perot Systems Awarded Contract to Implement Health Information System in Kingdom of Jordan 2Health News:Perot Systems Awarded Contract to Implement Health Information System in Kingdom of Jordan 3Health News:Largest study of fertility patients shows concerns about embryo disposition 2Health News:Largest study of fertility patients shows concerns about embryo disposition 3Health News:Jolie-Pitt Foundation Awards Second Grant to Global Action for Children 2
...g less may be due to other reasons// than age itse...that had been associated with increased age for th...l at all. Instead, the findings of the research sh...olved that can lead to insomnia or lack of sleep f...
... a public notice regarding the fatal adverse event... atypical antipsychotic drugs. The notice was issu...y demented patients who were treated with the drug...7 times more likely to die than patients given pla...
...s against the general thought that chocolate is ba...te can actually improve heart function. Athens Med...ts of dark chocolate consumption on blood vessel f...lthy subjects. The scientists found that these sub...
...n of the gene involved in causing// the condition ...gia. Investigators from Yale School of Medicine ha...ngle mutation of the gene for sodium channel Nav1....from the chronic condition of primary erythromelal...
Other Medicine News:
(Date:12/3/2008)...GO, Dec. 3 Vical Incorpo...ive, binding letter of intent with EIP,Eczacibasi... of the company,s,Allovectin-7(R) immunotherapeut...public of Northern Cyprus. EIP has agreed to obtai...itory and to pay Vical upfront and milestone payme...
(Date:12/2/2008)...A, Calif., Dec. 2 TorreyPines Ther...ositive results from a 26 patient Phase II trial e... xerostomia, or dry mouth, in patients with Sjogre...a statistically significant increase in salivary f...ses: 10 mg, 15 mg, and 20 mg. These doses were saf...
(Date:12/1/2008)...LE, Md., Dec. 1 Vanda Ph...cation in The Lancet , one of the world,s leading...ts novel circadian regulator, experimental compoun...atnam et al(1) is entitled "Melatonin agonist tasi...ep-time shift: two randomised controlled multicent...
(Date:12/1/2008)...e study shows the Prox1 gene is a two-way switch t...ells to be reprogrammed so that they lose their id...s , , MEMPHIS, Tenn., Dec. 1 /PRNewswire-US...search Hospital have discovered that a certain dif...entity that it requires the constant expression of...
Breaking Medicine Technology:Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 2Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 4Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 5TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 2TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 3TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 4TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 5Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Genomas Awarded 241 2 Million NIH SBIR Grant to Develop DNA Guided System for Management of Statin Therapy 4086 1Genomas Awarded 241 2 Million NIH SBIR Grant to Develop DNA Guided System for Management of Statin Therapy 4086 2Women at Higher Risk of Abnormal Burn Scars 14732 1Women at Higher Risk of Abnormal Burn Scars 14732 2Neuronal regulators offer potential targets for cancer 14730 1Neuronal regulators offer potential targets for cancer 14730 2NHS Choices Launches New Good Food Package 14729 1